180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
6.95
-1.97%
After-hours: Aug 15, 2025, 04:11 PM EDT

180 Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 95.11K n/a n/a n/a 166.03K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 47.56K 13.85K 23.98K 23.58K 83.02K 32.69K 28.55K 21.77K 37.61K 7.97K 36.96K 26.46K 23.16K 34.95K 29.52K 28.67K
Gross Profit
n/a n/a 47.56K -13.85K -23.98K -23.58K 83.02K -32.69K -28.55K -21.77K -37.61K -7.97K -36.96K -26.46K -23.16K -34.95K -29.52K -28.67K
Operating Income
-1.73M -2.37M -1.41M -979.09K -1.85M -2.09M -1.45M -3.54M -3.68M -4.8M -5.64M -4.06M -4.52M -3.68M -4.46M -4.22M -4.01M -2.95M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.56K n/a n/a n/a n/a
Pretax Income
-1.73M -2.37M -4.57M -836.72K 11.78K -1.07M -1.23M -12.61M -3.68M -4.76M -22.69M -21.49M 2.94M 1.56M 1.03M 18.29M -23.46M -16.2M
Net Income
-1.73M -2.37M -4.27M -836.72K 11.78K -1.07M -1.23M -10.27M -3.68M -4.76M -21.74M -21.49M 2.94M 1.56M 1.04M 18.3M -23.46M -16.2M
Selling & General & Admin
1.41M 2M 997.59K 576.38K 1.22M 1.53M 1.49M 2.43M 2.76M 4.01M 5.05M 3.42M 4.02M 2.97M 2.49M 3.6M 3.02M 2.58M
Research & Development
182.39K 240.91K 408.84K 402.71K 621.99K 535.73K 36.36K 1.1M 920.9K 794.99K 585.69K 636.52K 503.69K 706.66K 1.97M 615.35K 994.5K 366.95K
Other Expenses
140.37K 135.46K n/a n/a n/a n/a -72.72K n/a -14.42K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.73M 2.37M 1.41M 979.09K 1.85M 2.07M 1.45M 3.54M 3.67M 4.8M 5.64M 4.06M 4.52M 3.68M 4.46M 4.22M 4.01M 2.95M
Interest Expense
-2.67K -2.65K 9.2K 13.63K 11.36K 16.45K 10.03K 11.63K 11.61K 11.56K 4.55K 8.88K 8.89K 7.41K 13.29K 19.66K 26.38K 126.88K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -23.58K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.73M 2.37M 1.41M 979.09K 1.85M 2.09M 1.45M 3.54M 3.67M 4.8M 5.64M 4.06M 4.52M 3.68M 4.46M 4.22M 4.01M 2.95M
Income Tax Expense
n/a n/a -296.02K n/a n/a n/a -4.39K -2.35M n/a n/a 942.75K n/a n/a n/a 6.62K 5.61K 5.57K 5.4K
Shares Outstanding (Basic)
5.71M 3.54M 980.64K 980.64K 919.14K 638.34K 622K 418K 275K 197.22K 117K 103K 89K 89K 90K 88.71K 82K 73K
Shares Outstanding (Diluted)
5.71M 3.54M 980.64K 980.64K 919.14K 638.34K 622.86K 418.52K 275.33K 197.22K 117.42K 103.11K 89.77K 89.66K 89.34K 88.71K 82.79K 73.56K
EPS (Basic)
-0.3 -0.67 -12.97 -0.85 0.01 -1.68 -1.97 -24.56 -13.38 -24.15 -185.83 -208.61 32.74 17.45 11.60 212.44 -286.09 -221.9
EPS (Diluted)
-0.3 -0.67 -12.97 -0.85 0.01 -1.68 -1.97 -24.53 -13.37 -24.15 -185.16 -208.39 32.68 17.45 11.57 88.03 -283.37 -220.21
EBITDA
-1.73M -2.37M -4.56M -809.24K 47.12K -1.03M -1.2M -12.57M -3.64M -4.73M -22.64M -21.47M 2.99M 1.6M 1.07M 18.35M -23.41M -16.05M
EBIT
-1.72M -2.37M -4.56M -823.09K 23.14K -1.05M -1.22M -12.6M -3.67M -4.75M -22.68M -21.48M 2.95M 1.57M 1.04M 18.31M -23.44M -16.08M
Depreciation & Amortization
n/a 14.57K -3.13K 13.85K 23.98K 23.58K 22.66K 32.69K 28.55K 21.77K 37.61K 7.97K 36.96K 26.46K 23.16K 34.95K 29.52K 28.67K